AJANTPHARM.NS Shariah Compliance

Screening Methodology: AAOIFI

lock image
LOCKED

Analyst's Ratings

Based on 16 analysts giving stock ratings to Ajanta Pharma Ltd in the past 3 months

Strong
Sell
SellHoldBuyStrong
Buy
Strong Buy
38
Buy
44
Hold
6
Sell
6
Strong Sell
6
Ajanta Pharma Ltd

Ajanta Pharma Ltd. Stock Analysis AJANTPHARM.NS

India Health Care Mega Cap
Ajanta Pharma Ltd. is a holding company, which engages in the development, manufacture, and marketing of pharmaceutical products. The company is headquartered in Mumbai, Maharashtra and currently employs 7,844 full-time employees. The company went IPO on 2000-06-05. The company provides a comprehensive range of specialty branded generic products targeting a broad range of chronic and acute therapies. The company is focused on branded generic businesses across India, Asia and Africa. The company has a wide range of therapeutic segments, such as cardiology, anti-diabetes, ophthalmology, dermatology, antibiotic, anti-malarial, pain, respiratory, gynecology, pediatric and general health products. Its business also consists of two verticals: the United States generics and the institutional business in Africa. Its ophthalmology products include Bimat (anti glaucoma), Nepaflam (anti-inflammatory), Softdrops (lubricant), and Olopat (anti-allergic). Its cardiology products include MET XL, Atorfit CV, Antihypertensive Cinod, Rosutor Gold, Dapalex and Vilatin. Its subsidiaries include Ajanta Pharma (Mauritius) Limited, Ajanta Pharma USA Inc., Ajanta Pharma Philippines Inc., and Ajanta Pharma Nigeria Limited.
Read More

AJANTPHARM.NS Chart

India Health Care Mega Cap

Key Statistics

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

₹2,484.10₹2,532.60

Today's Open

₹2,519.80

Volume

75.64K

P/E Ratio (TTM)

41.25

52 Week Range

₹2,051.60₹3,485.00

Market Cap

340.57B

Avg. Volume

95.99K

Dividend Yield

0.97%

Financial Metrics & Statements

  • Per Share Data
  • Ratios
  • Statements
Currency: USD20202021202220232024
Revenue per Share (TTM)
197.55 222.28 258.99 297.24 334.25
EBIT per Share (TTM)
45.53 68.68 62.98 54.09 83.6
Dividend per Share (TTM)
8.66 6.38 6.37 7.12 51
EPS Forward
53.76 49.92 54.82 45.89 64.77

Community-Curated Collections ( With AJANTPHARM.NS )

View All

Community-Curated Collections are thoughtfully selected groups of stocks or assets, curated by investors and experts based on shared themes, values, or investment strategies.

FAQ's

Halal stocks refer to shares of companies that comply with Islamic finance principles, meaning they do not engage in businesses related to alcohol, gambling, pork, or interest-based financial services.